2020 官网升级中！
现在您访问官网的浏览器设备分辨率宽度低于1280px请使用高分辨率宽度访问。
COMPANY
R&D
PRODUCTS
PIPELINES
NEWS
PARTNERING
CAREERS
中
CONTACT US
HOME
COMPANY
R&D
PRODUCTS
PIPELINES
NEWS
PARTNERING
CAREERS
CONTACT US
中
RESEARCH & DEVELOPMENT
As a pioneer in China’s biopharmaceutical industry, we have deep expertise in discovering, developing, manufacturing antibody-based therapies
Scrllo Down
HOME
R&D
Antibody Discovery
Our Platform
• Established phage display libraries
• Affinity maturation of human antibodies
Cell Line Development
Our Platform
• Vector design & engineering
• Established mammalian recombinant protein expression systems
New mAb Technologies
Our Platform
• Antibody-drug conjugates platform
• New mAb and fusion protein engineering
• Bi-specific and tri-specific mAb platform
Analytics
Our Platform
• In house protein analytics/characterization suite to support process development
CMC Development and GMP Manufacturing
Our Platform
• Proprietary serum-free culture medium
• Robust PC/PV development platform
• In house developability analysis & formulation development
Commercial Manufacturing
Our Platform
• 8 x 2250L mammalian bioreactors and purification suite in operation
• Leading production capability in China with new plants in planning for 2022
To Learn More
CONTACT US
TO TOP
Antibody Discovery
Cell Line Development
New mAb Technologies
Analytics
CMC Development and GMP Manufacturing
Commercial Manufacturing
